Australia has issued an advisory warning of counterfeit rabies vaccine batches, Abhayrab, circulating in India since late 2023. The vaccine's manufacturer, Indian Immunologicals Limited (IIL), has contested the advisory's scope, stating the issue is limited to a single counterfeit batch identified in January 2025. IIL claims this batch was detected, reported to authorities, and is no longer in circulation, urging Australia to review its alert to prevent public anxiety and mistrust.